Abstract
Worldwide, 1% of the population receives anticoagulation therapy, with prevalence higher in older adults. Difficulties in the adequate management of these patients have led to the development of strategies focused on achieving therapeutic control and reducing adverse events with efficient use of resources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have